Increased atherosclerosis in myeloperoxidase-deficient mice

Journal of Clinical Investigation

Volumn 107, Issue 4, 2001, Pages 419-430

  Brennan, M L ^a   Anderson, M M ^a   Shih, D M ^a   Qu, X D ^a   Wang, X ^a   Mehta, A C ^a   Lim, L L ^a   Shi, W ^a   Hazen, S L ^a   Jacob, J S ^a   Crowley, J R ^a   Heinecke, J W ^a   Lusis, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CANDIDA ALBICANS; CHOLESTEROL DIET; ENZYME DEFICIENCY; GENE OVEREXPRESSION; HYPERCHOLESTEROLEMIA; LEUKOCYTE COUNT; LIPID DIET; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0035110605     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8797     Document Type: Article

References (88)

1. Verdoperoxidase: A ferment isolated from leukocytes
2. Oxygen-dependent microbial killing by phagocytes
3. Tissue destruction by neutrophils
4. Myeloperoxidase of the leucocyte of normal human blood. 1. Content and localization
5. Characterization and quantification of the peroxidase in human monocytes
6. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
7. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
8. Studies on the chlorinating activity of myeloperoxidase
9. Assessment of chlorination by human neutrophils
10. Brominating oxidants generated by human eosinophils
11. A peroxidase-mediated antimicrobial system in leukocytes
12. Myeloperoxidase: Contribution to the microbicidal activity of intact leukocytes
13. Myeloperoxidase deficiency
14. Molecular genetics of peroxidase deficiency
15. Leukocyte myeloperoxidase-deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection
16. Defective bactericidal activity in myeloperoxidase-deficient human neutrophils
17. Oxygen metabolism and the toxic properties of phagocytes
18. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
19. Myeloperoxidase-generated oxidants and atherosclerosis
20. Presence of hypochlorite-modified proteins in human atherosclerotic lesions
21. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
22. Immunological evidence for hypochlorite-modified proteins in human kidney
23. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination
24. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia
25. Myeloperoxidase genetic polymorphism and lung cancer risk
26. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
27. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
28. Biological reactivity of hypochlorous acid: Implications for microbicidal mechanisms of leukocyte myeloperoxidase
29. Myeloperoxidase-catalyzed incorporation of amines into proteins: Role of hypochlorous acid and dichloramines
30. Chlorination of taurine by human neutrophils. Evidence of hypochlorous acid generation
31. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid
32. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: Potential markers for lipoproteins oxidatively damaged by phagocytes
33. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols
34. Chlorination of tyrosyl radical in peptides by myeloperoxidase and human neutrophils
35. Human neutrophils employ chlorine gas as an oxidant during phagocytosis
36. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages
37. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for inititation of lipid peroxidation in low density lipoprotein
38. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative crosslinking of proteins
39. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity
40. Relative chlorinating, nitrating and oxidizing capabilities of neutrophil determined with phagocytosable probes
41. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
42. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
43. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein
44. Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics
45. Atherosclerosis
46. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
47. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
48. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
49. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
50. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages
51. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation
52. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
53. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase
54. Sequence of the murine myeloperoxidase (MPO) gene
55. Characterization of cDNA clones for human myeloperoxidase: Predicted amino acid sequence and evidence for multiple mRNA species
56. Simplified myeloperoxidase stain using benzidine dihydrochloride
57. Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells
58. Assays for the chlorination activity of myeloperoxidase
59. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
60. Interaction of Candida Albicans with human leukocytes and serum
61. Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils
62. Speed congenics: A classic technique moves into the fast lane (relatively speaking)
63. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
64. Mildly oxidized LDL induces apolipoprotein J/paraoxonase ratio
65. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
66. Pathology of atheromatous lesions in inbred and genetically engineered mice: Genetic determination of arterial calcification
67. Structure of the green heme in myeloperoxidase
68. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
69. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
70. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
71. Ath-1, a gene determining atherosclerosis susceptibility, and high density lipoprotein levels in mice
72. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. An inflammatory control mechanism
73. Oxidative autoactivation of latent collagenase by human neutrophils
74. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system
75. Neutrophil chloramines: Missing links between innate and acquired immunity
76. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells
77. Exercise and cardiovascular disease: A new perspective
78. Nitric oxide is a physiologic substrate for mammalian peroxidases
79. Granule enzymes of polymorphonuclear neutrophils: A phylogenetic comparison
80. Identification and functional analysis of multiple murine myeloperoxidase (MPO) promoters and comparison with the human MPO promoter region
81. Nitric oxide modulates the catalytic activity of myeloperoxidase
82. Aortic wall damage in mice unable to synthesize ascorbic acid
83. Termination of the respiratory burst in human neutrophils
84. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice
85. Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase